Catalyst Capital Advisors’s Zepp Health ZEPP Stock Holding History

Catalyst Capital Advisors’s Portfolio ZEPP Stock Details ZEPP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-106	Closed	-$5K	–	568
2018 Q1	$5K	Buy	+106	New	+$4.7K	﹤0.01%	413

Other funds holding ZEPP

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tairen Capital Hong Kong $924M AUM 105.21% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Formula Growth Montreal, Quebec, Canada $222M AUM 27.84% 1-Year Est. Return

ACM

Ativo Capital Management Chicago, Illinois $115M AUM 19.02% 1-Year Est. Return

MIM

Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SPM

Symmetry Peak Management Radnor, Pennsylvania $359M AUM 146.87% 1-Year Est. Return

Catalyst Capital Advisors's ZEPP Position: Q2 2018 in Review

Catalyst Capital Advisors sold out of Zepp Health (ZEPP) in Q2 2018, closing a stake of 106 shares — an estimated $5K sold.

Catalyst Capital Advisors first reported a position in ZEPP in Q1 2018 and held it in 1 quarter. The position peaked at $5K in Q1 2018. 20 funds tracked by Wall St. Rank hold ZEPP as of Q2 2018.

Catalyst Capital Advisors reported no remaining Zepp Health position as of Q2 2018 after selling out during the quarter.
Catalyst Capital Advisors sold 106 Zepp Health shares in Q2 2018, an estimated $5K.
Catalyst Capital Advisors first reported a position in Zepp Health in Q1 2018 and held it in 1 quarter.
Catalyst Capital Advisors's Zepp Health position peaked at $5K in Q1 2018.
20 funds tracked by Wall St. Rank held Zepp Health as of Q2 2018.

Based on Catalyst Capital Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.